Effect of Oral Pregabalin on Spinal Neurotransmitters in Patients Undergoing Knee Replacement

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
PAIN
Interventions
DRUG

Pregabalin

"Group 1 (n=16, multi-dose pregabalin): patients receive pregabalin 150 mg orally 1 hour prior to surgery and then repeat 150 mg doses at 12 and 24 hours after initial dose.~Group 2 (n=16, single dose pregabalin): patients receive pregabalin 150 mg orally 1 hour prior to surgery, and then placebo doses at 12 and 24 hours after initial dose.~Group 3 (n=16, placebo): patients receive matching placebo at the same 3 time points as Groups 1 and 2."

DRUG

Pregabalin

Group 2 (n=16, single dose pregabalin): patients receive pregabalin 150 mg orally 1 hour prior to surgery, and then placebo doses at 12 and 24 hours after initial dose.

DRUG

Placebo

Group 3 (n=16, placebo): patients receive matching placebo at the same 3 time points as Groups 1 and 2.

Trial Locations (1)

60612

Rush University Medical Center, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Asokumar Buvanendran

OTHER